A decade of complement inhibition in post-transplant atypical HUS: outcomes with eculizumab and ravulizumab

2026-06-10

Naga Sumanth Reddy Gopireddy

Abhishek Kumar

Richard J H Smith

Carla M Nester

Christie P Thomas *

DOI：10.1093/ckj/sfag198

Original request for help

Save

Abstract

IF:

4.6

Papers:

2.9K

Citations:

7.1K

Scholars:

3.6K

Papers: 1.5K

Citations: 1

Scholars:

2.4K

Papers: 955

Citations: 3